medigraphic.com
ISSN 1561-302X (Print)

2022, Number 4

<< Back Next >>

Rev cubana med 2022; 61 (4)

Factors associated with survival in systemic sclerosis

Estévez TMH, Chico CA, Zea GAM, Tamargo BTO, Kokuina E, Arguelles ZAC

Language: Spanish
References: 28
Page: 1-12
PDF size: 376.69 Kb.


ABSTRACT

Introduction: Systemic sclerosis is an autoimmune disease, of unknown cause.
Objective: To determine survival in patients with systemic sclerosis, variables associated with systemic sclerosis and causes of death.
Methods: A retrospective observational study was conducted in patients with systemic sclerosis, attended in the rheumatology service of the "Hermanos Ameijeiras" Hospital from January 3, 2005 to December 31, 2018, the survival rate, causes of death and associated variables were determined. The Kaplan-Meier method was used to determine survival rates. For the identification of independent variables associated with mortality, Cox regression was used with the calculation of relative risks with their respective 95 % confidence intervals. A significance level of <0.05 was set for all hypothesis tests.
Results: 131 patients (119 women, 12 men) were included. Overall survival was 92 %, 87 %, 80 %, at 5 years, 10 years and 15 years respectively, 18 patients died (13.7 %), the most frequent cause of death was interstitial lung disease (40 %), variables associated with mortality were the diffuse form of the disease, the presence of intestinal malabsorption and pulmonary hypertension: Remarkable survival rates were achieved, the presence of pulmonary hypertension constituted a risk factor for mortality and the limited clinical form was shown to be a protective factor in terms of mortality.


REFERENCES

  1. Simeon Aznar CP, Fonollosa Pla V, Carles TV, Espinosa Garriga G, Campillo Grau M, Casals Ramos M, et al. Registry of the Spanish Network for Systemic Sclerosis: survival, prognostic factors, and causes of death. Medicine 2015;94(43):e1728. DOI : https://doi.org/10.1097/MD.0000000000001728

  2. Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir Guzman A, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017;76:1897-905. DOI: https://doi.org/10.1136/annrheumdis-2017-211448

  3. Chung L, Utz PJ. Antibodies in scleroderma: direct pathogenicity and phenotypic associations. Curr Rheumatol Rep. 2004;6:156-63. DOI: https://doi.org/10.1007/s11926-004-0061-9

  4. Rubio Rivas M, Royo C, Simeon CP, Corbella X, Fonollosa V. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 2014;44:208-19. DOI: https://doi.org/10.1016/j.semarthrit.2014.05.010

  5. Hao Y, Hudson M, Baron M, Carreira P, Stevens W, Rabusa C, et al. Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheumatol 2017;69:1067-77. DOI: https://doi.org/10.1002/art.40027

  6. Nihtyanova SI, Schereiber BE, Ong VH, Rosenberg D, Moinzadeh P,Coghlan JG ,et al. Prediction of pulmonary complications and Survivalo in SSc. Arthritis Rheumatol 2014;66:1625-35. DOI: https://doi.org/10.1002/art.38390

  7. Zhang S Z, Xu D, Li MT, Hou Y, Wang Q, Tian Z, et al. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China. Clin Exp Rheumatol 2015 [acceso: 18/02/2020];33(4Suppl 91):106-10. Disponible en: Epub. PMID: 26005882.

  8. Broen JC, Radstake TR, Rossato. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat. Rev. Rheumatol. 2014;10:671-81. DOI: https://doi.org/10.1038/nrrheum.2014.128

  9. Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA. A clinical and serologic comparison of African- American and Caucasian patients with systemic sclerosis. Arthritis Rheum. 2012,64(9):2986-94. DOI: https://doi.org/10.1002/art.34482

  10. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581-90. DOI: https://doi.org/10.1002/art.1780230510

  11. Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against rheumatism collaborative initiative: ACR/EULAR classification criteria for SSc. Arthritis Rheum. 2013;65:2737-47 DOI: https://doi.org/10.1002/art.38098

  12. Le Roy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-5.

  13. Bennett R, Bluestone R, Holt PJ, Bywaters EG. Survival in scleroderma. Ann Rheum Dis. 1971;64 30:581-8. DOI: https://doi.org/10.1136/ard.30.6.581

  14. Hu S, Hou Y, Wang Q, Li M, Xu D, Zeng X. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China. Arthritis Res Ther. 2018,20:235. DOI : https://doi.org/10.1186/s13075-018-1735-4

  15. Poormoghim H, Andalib E, Jalali A, Gadheri A, Gorbannia A, Mojtabavi N. Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran. Rheumatol Int. 2016;36(7):925-34. DOI: https://doi.org/10.1007/s00296-016-3475-6

  16. Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J. Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int. 2017;37(12):1-8. DOI : https://doi.org/10.1007/s00296-017-3846-7

  17. Ferri C, Sebastiani M, Monaco AL, Ludici M Furini F,Giuggioli D, et al. Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev. 2014;13(10):1026-34. DOI: https://doi.org/10.1016/j.autrev.2014.08.029

  18. Pokeerbux MR, Giovannelli J, Dauchet L, Mouthon L, Agard C, Lega JC, et al. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta- analysis of the literature. Arthritis Research Therapy. 2019;21:86. DOI: https://doi.org/10.1186/s13075-019-1867-1

  19. Gottschalk P, Vásquez R, López PD, Then J, Tineo C, Loyo E. Esclerodermia en el Caribe: características en una serie de casos dominicana. Reumatol Clin 2014;10(6):373-9. DOI: https://doi.org/10.1016/j.reuma.2014.01.011

  20. Cruz Domínguez MP, Casarrubias Ramírez M, Gasca Martínez V, Maldonado García C, Carranza Muleiro RA, Medina G, et al .Cuestionario de funcionalidad para esclerosis sistémica (SySQ): validación en español del original en alemán y su relación con la enfermedad y la calidad de vida. Reumatol Clin 2019;15(5):282-8. DOI: https://doi.org/10.1016/j.reuma.2017.09.001

  21. Li X, Guan Quian YU, Liu NA, Mu R, Zuo YU, Guo Chun W, et al. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study. Clinical Rheumatology 2018;37:3051-6. DOI: https://doi.org/10.1007/s10067-018-4291-z

  22. Freire M, Rivera A, Sopeña B, Tolosa Vilella C, Guillen del Castillo A, Colunga Arguelles D, et al. Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review. Clin Exp Rheumatol 2017;35(Suppl. 106): 89-97. Disponible en: Epub 2017. PMID: 28980905.

  23. Melody P, Dontsi M, Postlethwaite D, Kesh S, Simard JF, Florentino D, et al. Increased Mortality in Asians with Systemic Sclerosis in Northern California. ACR Open Rheumatol. 2020;2(4):197-206. DOI: https://doi.org/10.1002/acr2.11126

  24. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43:2437-44. DOI: https://doi.org/10.1002/1529-0131(200011)43:11<2437:AID-ANR10>3.0.CO;2-U

  25. Jaovisidha K, Csuka ME, Almagro UA, Soergel KH. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of literature. Semin Arthritis Rheum. 2005;34:689-702. DOI: https://doi.org/10.1016/j.semarthrit.2004.08.009

  26. Joven BE, Almodovar, Carmona L, Carreira PE. Survival, causes of death and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum 2010;39:285-93. DOI : https://doi.org/10.1016/j.semarthrit.2009.06.002

  27. Lefevre G, Dauchet L, Hachulla E, Montani D, Sobanski V, Lambert M, et al. Survival and prognostic factors in systemic sclerosis–associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum. 2013;65:2412-23. DOI: https://doi.org/10.1002/art.38029

  28. Hashimoto A, Tejima S, Tono T. Predictors of survival and causes of death in Japanese patients with systemic sclerosis. JR Hematol. 2001;38(9):1931-9. DOI: https://doi.org/10.3899/jrheum.100298




2020     |     www.medigraphic.com